Chronic Morphine Treatment and Withdrawal Increase Extracellular Levels of Norepinephrine in the Rat Bed Nucleus of the Stria Terminalis

Extracellular levels of norepinephrine (NE) and glutamate (Glu) in the ventral bed nucleus of the stria terminalis (vBNST) of saline‐ and chronic morphine‐treated rats, with or without withdrawal, were studied by means of the in vivo microdialysis technique in anesthetized rats. In addition, the tis...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of neurochemistry 2000-08, Vol.75 (2), p.741-748
Hauptverfasser: Fuentealba, José Antonio, Forray, María Inés, Gysling, Katia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 748
container_issue 2
container_start_page 741
container_title Journal of neurochemistry
container_volume 75
creator Fuentealba, José Antonio
Forray, María Inés
Gysling, Katia
description Extracellular levels of norepinephrine (NE) and glutamate (Glu) in the ventral bed nucleus of the stria terminalis (vBNST) of saline‐ and chronic morphine‐treated rats, with or without withdrawal, were studied by means of the in vivo microdialysis technique in anesthetized rats. In addition, the tissue concentration of NE was studied at different rostrocaudal levels of the vBNST. Chronic morphine treatment significantly increased extracellular levels of NE, but not Glu, in vBNST. At 48 h after naloxone‐induced morphine withdrawal there was a further significant increase in the extracellular levels of NE, but not Glu, in vBNST. The presence of UK 14304, an α2‐adrenergic agonist, induced a significant decrease in NE extracellular levels in all experimental groups. In contrast, UK 14304 induced a significant decrease in Glu extracellular levels only in saline‐treated rats. The results also show that the vBNST presents a rostrocaudal gradient of NE and contains 9.4% of total brain NE. The increase in NE extracellular levels in vBNST induced by chronic morphine treatment and the further increase in NE levels 48 h after naloxone‐induced morphine withdrawal suggest that NE in vBNST may be involved in the pharmacological effects of chronic morphine and withdrawal.
doi_str_mv 10.1046/j.1471-4159.2000.0750741.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17605836</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17605836</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5521-3b5e56cb1844cb4fd3edc43456f8de34f78b7e5540ce9aaad3147c4178d9eda13</originalsourceid><addsrcrecordid>eNqVkcuO1DAQRS0EYpqBX0AWQuwS7MTOgx3TGmBQ00jQiKVVsSuKW85j7ITp-QM-m4SOgC0ry65Tt8r3EvKCs5gzkb0-xlzkPBJclnHCGItZLlkueHx6QDZ_Sg_JhrEkiVImkgvyJIQjYzwTGX9MLjgryrKUbEN-bhvfd1bTT70fGtshPXiEscVupNAZ-t2OjfFwB47edHouBaTXp9GDRucmB57u8Ae6QPua7nuPwywxNH4Rsh0dG6RfYKRXaOh-0g6n3-Dy_HX0FugBfWs7cDY8JY9qcAGfrecl-fbu-rD9EO0-v7_Zvt1FWsqER2klUWa64oUQuhK1SdFokQqZ1YXBVNR5UeUopWAaSwAw6WyIFjwvTIkGeHpJXp11B9_fThhG1dqwfAY67KegeJ4xWaTZDL45g9r3IXis1eBtC_5ecaaWHNRRLWarxWy15KDWHNRpbn6-TpmqFs0_rWfjZ-DlCkDQ4GoPnbbhLyd5ItiyxNUZu7MO7_9jA_Vxv10v6S8m7Kas</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17605836</pqid></control><display><type>article</type><title>Chronic Morphine Treatment and Withdrawal Increase Extracellular Levels of Norepinephrine in the Rat Bed Nucleus of the Stria Terminalis</title><source>MEDLINE</source><source>Wiley Online Library Free Content</source><source>Access via Wiley Online Library</source><source>IngentaConnect Free/Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Free Full-Text Journals in Chemistry</source><creator>Fuentealba, José Antonio ; Forray, María Inés ; Gysling, Katia</creator><creatorcontrib>Fuentealba, José Antonio ; Forray, María Inés ; Gysling, Katia</creatorcontrib><description>Extracellular levels of norepinephrine (NE) and glutamate (Glu) in the ventral bed nucleus of the stria terminalis (vBNST) of saline‐ and chronic morphine‐treated rats, with or without withdrawal, were studied by means of the in vivo microdialysis technique in anesthetized rats. In addition, the tissue concentration of NE was studied at different rostrocaudal levels of the vBNST. Chronic morphine treatment significantly increased extracellular levels of NE, but not Glu, in vBNST. At 48 h after naloxone‐induced morphine withdrawal there was a further significant increase in the extracellular levels of NE, but not Glu, in vBNST. The presence of UK 14304, an α2‐adrenergic agonist, induced a significant decrease in NE extracellular levels in all experimental groups. In contrast, UK 14304 induced a significant decrease in Glu extracellular levels only in saline‐treated rats. The results also show that the vBNST presents a rostrocaudal gradient of NE and contains 9.4% of total brain NE. The increase in NE extracellular levels in vBNST induced by chronic morphine treatment and the further increase in NE levels 48 h after naloxone‐induced morphine withdrawal suggest that NE in vBNST may be involved in the pharmacological effects of chronic morphine and withdrawal.</description><identifier>ISSN: 0022-3042</identifier><identifier>EISSN: 1471-4159</identifier><identifier>DOI: 10.1046/j.1471-4159.2000.0750741.x</identifier><identifier>PMID: 10899950</identifier><identifier>CODEN: JONRA9</identifier><language>eng</language><publisher>Oxford UK: Blackwell Science Ltd</publisher><subject>Adrenergic alpha-Agonists - pharmacology ; Animals ; bed nucleus ; Biological and medical sciences ; Brain - drug effects ; Brain - metabolism ; Brimonidine Tartrate ; Extracellular Space - drug effects ; Extracellular Space - metabolism ; Glutamic Acid - metabolism ; In Vitro Techniques ; Male ; Medical sciences ; Microdialysis ; Morphine ; Morphine - pharmacology ; Morphine Dependence - metabolism ; Naloxone ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Norepinephrine ; Norepinephrine - metabolism ; Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems ; Pharmacology. Drug treatments ; Quinoxalines - pharmacology ; Rats ; Rats, Sprague-Dawley ; Septal Nuclei - drug effects ; Septal Nuclei - metabolism ; Substance Withdrawal Syndrome - metabolism ; Ventral bed nucleus of the stria terminalis ; Withdrawal</subject><ispartof>Journal of neurochemistry, 2000-08, Vol.75 (2), p.741-748</ispartof><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5521-3b5e56cb1844cb4fd3edc43456f8de34f78b7e5540ce9aaad3147c4178d9eda13</citedby><cites>FETCH-LOGICAL-c5521-3b5e56cb1844cb4fd3edc43456f8de34f78b7e5540ce9aaad3147c4178d9eda13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1046%2Fj.1471-4159.2000.0750741.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1046%2Fj.1471-4159.2000.0750741.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,1433,27924,27925,45574,45575,46409,46833</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1512406$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10899950$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fuentealba, José Antonio</creatorcontrib><creatorcontrib>Forray, María Inés</creatorcontrib><creatorcontrib>Gysling, Katia</creatorcontrib><title>Chronic Morphine Treatment and Withdrawal Increase Extracellular Levels of Norepinephrine in the Rat Bed Nucleus of the Stria Terminalis</title><title>Journal of neurochemistry</title><addtitle>J Neurochem</addtitle><description>Extracellular levels of norepinephrine (NE) and glutamate (Glu) in the ventral bed nucleus of the stria terminalis (vBNST) of saline‐ and chronic morphine‐treated rats, with or without withdrawal, were studied by means of the in vivo microdialysis technique in anesthetized rats. In addition, the tissue concentration of NE was studied at different rostrocaudal levels of the vBNST. Chronic morphine treatment significantly increased extracellular levels of NE, but not Glu, in vBNST. At 48 h after naloxone‐induced morphine withdrawal there was a further significant increase in the extracellular levels of NE, but not Glu, in vBNST. The presence of UK 14304, an α2‐adrenergic agonist, induced a significant decrease in NE extracellular levels in all experimental groups. In contrast, UK 14304 induced a significant decrease in Glu extracellular levels only in saline‐treated rats. The results also show that the vBNST presents a rostrocaudal gradient of NE and contains 9.4% of total brain NE. The increase in NE extracellular levels in vBNST induced by chronic morphine treatment and the further increase in NE levels 48 h after naloxone‐induced morphine withdrawal suggest that NE in vBNST may be involved in the pharmacological effects of chronic morphine and withdrawal.</description><subject>Adrenergic alpha-Agonists - pharmacology</subject><subject>Animals</subject><subject>bed nucleus</subject><subject>Biological and medical sciences</subject><subject>Brain - drug effects</subject><subject>Brain - metabolism</subject><subject>Brimonidine Tartrate</subject><subject>Extracellular Space - drug effects</subject><subject>Extracellular Space - metabolism</subject><subject>Glutamic Acid - metabolism</subject><subject>In Vitro Techniques</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Microdialysis</subject><subject>Morphine</subject><subject>Morphine - pharmacology</subject><subject>Morphine Dependence - metabolism</subject><subject>Naloxone</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Norepinephrine</subject><subject>Norepinephrine - metabolism</subject><subject>Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems</subject><subject>Pharmacology. Drug treatments</subject><subject>Quinoxalines - pharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Septal Nuclei - drug effects</subject><subject>Septal Nuclei - metabolism</subject><subject>Substance Withdrawal Syndrome - metabolism</subject><subject>Ventral bed nucleus of the stria terminalis</subject><subject>Withdrawal</subject><issn>0022-3042</issn><issn>1471-4159</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkcuO1DAQRS0EYpqBX0AWQuwS7MTOgx3TGmBQ00jQiKVVsSuKW85j7ITp-QM-m4SOgC0ry65Tt8r3EvKCs5gzkb0-xlzkPBJclnHCGItZLlkueHx6QDZ_Sg_JhrEkiVImkgvyJIQjYzwTGX9MLjgryrKUbEN-bhvfd1bTT70fGtshPXiEscVupNAZ-t2OjfFwB47edHouBaTXp9GDRucmB57u8Ae6QPua7nuPwywxNH4Rsh0dG6RfYKRXaOh-0g6n3-Dy_HX0FugBfWs7cDY8JY9qcAGfrecl-fbu-rD9EO0-v7_Zvt1FWsqER2klUWa64oUQuhK1SdFokQqZ1YXBVNR5UeUopWAaSwAw6WyIFjwvTIkGeHpJXp11B9_fThhG1dqwfAY67KegeJ4xWaTZDL45g9r3IXis1eBtC_5ecaaWHNRRLWarxWy15KDWHNRpbn6-TpmqFs0_rWfjZ-DlCkDQ4GoPnbbhLyd5ItiyxNUZu7MO7_9jA_Vxv10v6S8m7Kas</recordid><startdate>200008</startdate><enddate>200008</enddate><creator>Fuentealba, José Antonio</creator><creator>Forray, María Inés</creator><creator>Gysling, Katia</creator><general>Blackwell Science Ltd</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>200008</creationdate><title>Chronic Morphine Treatment and Withdrawal Increase Extracellular Levels of Norepinephrine in the Rat Bed Nucleus of the Stria Terminalis</title><author>Fuentealba, José Antonio ; Forray, María Inés ; Gysling, Katia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5521-3b5e56cb1844cb4fd3edc43456f8de34f78b7e5540ce9aaad3147c4178d9eda13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Adrenergic alpha-Agonists - pharmacology</topic><topic>Animals</topic><topic>bed nucleus</topic><topic>Biological and medical sciences</topic><topic>Brain - drug effects</topic><topic>Brain - metabolism</topic><topic>Brimonidine Tartrate</topic><topic>Extracellular Space - drug effects</topic><topic>Extracellular Space - metabolism</topic><topic>Glutamic Acid - metabolism</topic><topic>In Vitro Techniques</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Microdialysis</topic><topic>Morphine</topic><topic>Morphine - pharmacology</topic><topic>Morphine Dependence - metabolism</topic><topic>Naloxone</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Norepinephrine</topic><topic>Norepinephrine - metabolism</topic><topic>Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems</topic><topic>Pharmacology. Drug treatments</topic><topic>Quinoxalines - pharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Septal Nuclei - drug effects</topic><topic>Septal Nuclei - metabolism</topic><topic>Substance Withdrawal Syndrome - metabolism</topic><topic>Ventral bed nucleus of the stria terminalis</topic><topic>Withdrawal</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fuentealba, José Antonio</creatorcontrib><creatorcontrib>Forray, María Inés</creatorcontrib><creatorcontrib>Gysling, Katia</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Journal of neurochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fuentealba, José Antonio</au><au>Forray, María Inés</au><au>Gysling, Katia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Chronic Morphine Treatment and Withdrawal Increase Extracellular Levels of Norepinephrine in the Rat Bed Nucleus of the Stria Terminalis</atitle><jtitle>Journal of neurochemistry</jtitle><addtitle>J Neurochem</addtitle><date>2000-08</date><risdate>2000</risdate><volume>75</volume><issue>2</issue><spage>741</spage><epage>748</epage><pages>741-748</pages><issn>0022-3042</issn><eissn>1471-4159</eissn><coden>JONRA9</coden><abstract>Extracellular levels of norepinephrine (NE) and glutamate (Glu) in the ventral bed nucleus of the stria terminalis (vBNST) of saline‐ and chronic morphine‐treated rats, with or without withdrawal, were studied by means of the in vivo microdialysis technique in anesthetized rats. In addition, the tissue concentration of NE was studied at different rostrocaudal levels of the vBNST. Chronic morphine treatment significantly increased extracellular levels of NE, but not Glu, in vBNST. At 48 h after naloxone‐induced morphine withdrawal there was a further significant increase in the extracellular levels of NE, but not Glu, in vBNST. The presence of UK 14304, an α2‐adrenergic agonist, induced a significant decrease in NE extracellular levels in all experimental groups. In contrast, UK 14304 induced a significant decrease in Glu extracellular levels only in saline‐treated rats. The results also show that the vBNST presents a rostrocaudal gradient of NE and contains 9.4% of total brain NE. The increase in NE extracellular levels in vBNST induced by chronic morphine treatment and the further increase in NE levels 48 h after naloxone‐induced morphine withdrawal suggest that NE in vBNST may be involved in the pharmacological effects of chronic morphine and withdrawal.</abstract><cop>Oxford UK</cop><pub>Blackwell Science Ltd</pub><pmid>10899950</pmid><doi>10.1046/j.1471-4159.2000.0750741.x</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-3042
ispartof Journal of neurochemistry, 2000-08, Vol.75 (2), p.741-748
issn 0022-3042
1471-4159
language eng
recordid cdi_proquest_miscellaneous_17605836
source MEDLINE; Wiley Online Library Free Content; Access via Wiley Online Library; IngentaConnect Free/Open Access Journals; EZB-FREE-00999 freely available EZB journals; Free Full-Text Journals in Chemistry
subjects Adrenergic alpha-Agonists - pharmacology
Animals
bed nucleus
Biological and medical sciences
Brain - drug effects
Brain - metabolism
Brimonidine Tartrate
Extracellular Space - drug effects
Extracellular Space - metabolism
Glutamic Acid - metabolism
In Vitro Techniques
Male
Medical sciences
Microdialysis
Morphine
Morphine - pharmacology
Morphine Dependence - metabolism
Naloxone
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
Norepinephrine
Norepinephrine - metabolism
Peptidergic system (neuropeptide, opioid peptide, opiates...). Adenosinergic and purinergic systems
Pharmacology. Drug treatments
Quinoxalines - pharmacology
Rats
Rats, Sprague-Dawley
Septal Nuclei - drug effects
Septal Nuclei - metabolism
Substance Withdrawal Syndrome - metabolism
Ventral bed nucleus of the stria terminalis
Withdrawal
title Chronic Morphine Treatment and Withdrawal Increase Extracellular Levels of Norepinephrine in the Rat Bed Nucleus of the Stria Terminalis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T17%3A36%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Chronic%20Morphine%20Treatment%20and%20Withdrawal%20Increase%20Extracellular%20Levels%20of%20Norepinephrine%20in%20the%20Rat%20Bed%20Nucleus%20of%20the%20Stria%20Terminalis&rft.jtitle=Journal%20of%20neurochemistry&rft.au=Fuentealba,%20Jos%C3%A9%20Antonio&rft.date=2000-08&rft.volume=75&rft.issue=2&rft.spage=741&rft.epage=748&rft.pages=741-748&rft.issn=0022-3042&rft.eissn=1471-4159&rft.coden=JONRA9&rft_id=info:doi/10.1046/j.1471-4159.2000.0750741.x&rft_dat=%3Cproquest_cross%3E17605836%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17605836&rft_id=info:pmid/10899950&rfr_iscdi=true